Peripheral blood mononuclear cells hepatitis C virus RNA as a predictor for the response to daclatasvir-containing oral antiviral regimen in chronic hepatitis C patients from the Damietta Governorate
Background Eradication of hepatitis C virus (HCV) infection is the goal of direct-acting antivirals with a high rate of sustained virological response (SVR). Currently, SVR is determined by negative serum HCV RNA by real-time (RT)-PCR that may not give any information about intracellular HCV replica...
Saved in:
Main Authors: | Alaa E Hashim (Author), Samy Zaky (Author), Naglaa Azab (Author), Fathiya El-Raey (Author), Mahmoud A Halim (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta
by: Alaa Eldeen M Hashim, et al.
Published: (2020) -
Daclatasvir: potential role in hepatitis C
by: Lee C
Published: (2013) -
Daclatasvir: potential role in hepatitis C [Corrigendum]
by: Lee C
Published: (2014) -
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
by: Andrew Hill, et al.
Published: (2016) -
Frequency of Sustained Virologic Response in Hepatitis C Positive, Treatment Naïve Patients on Sofosbuvir and Daclatasvir
by: Islam Shah, et al.
Published: (2023)